Literature DB >> 17984454

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.

M Sarazin1, C Berr, J De Rotrou, C Fabrigoule, F Pasquier, S Legrain, B Michel, M Puel, M Volteau, J Touchon, M Verny, B Dubois.   

Abstract

OBJECTIVE: To compare the power of tests assessing different cognitive domains for the identification of prodromal Alzheimer disease (AD) among patients with mild cognitive impairment (MCI).
BACKGROUND: Given the early involvement of the medial temporal lobe, a precocious and specific pattern of memory disorders might be expected for the identification of prodromal AD.
METHODS: A total of 251 patients with MCI were tested at baseline by a standardized neuropsychological battery, which included the Free and Cued Selective Recall Reminding Test (FCSRT) for verbal episodic memory; the Benton Visual Retention Test for visual memory; the Deno 100 and verbal fluency for language; a serial digit learning test and the double task of Baddeley for working memory; Wechsler Adult Intelligence Scale (WAIS) similarities for conceptual elaboration; and the Stroop test, the Trail Making test, and the WAIS digit symbol test for executive functions. The patients were followed at 6-month intervals for up to 3 years in order to identify those who converted to AD vs those who remained stable over time. Statistical analyses were based on receiver operating characteristic curve and Cox proportional hazards models.
RESULTS: A total of 59 subjects converted to AD dementia. The most sensitive and specific test for diagnosis of prodromal AD was the FCSRT. Significant cutoff for the diagnosis was 17/48 for free recall, 40/48 for total recall, and below 71% for index of sensitivity of cueing (% of efficacy of semantic cues for retrieval).
CONCLUSIONS: The amnestic syndrome of the medial temporal type, defined by the Free and Cued Selective Recall Reminding Test, is able to distinguish patients at an early stage of Alzheimer disease from mild cognitive impairment non-converters.

Entities:  

Mesh:

Year:  2007        PMID: 17984454     DOI: 10.1212/01.wnl.0000279336.36610.f7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  137 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

Review 2.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

3.  Level of recall, retrieval speed, and variability on the Cued-Recall Retrieval Speed Task (CRRST) in individuals with amnestic mild cognitive impairment.

Authors:  Wendy S Ramratan; Laura A Rabin; Cuiling Wang; Molly E Zimmerman; Mindy J Katz; Richard B Lipton; Herman Buschke
Journal:  J Int Neuropsychol Soc       Date:  2012-01-23       Impact factor: 2.892

4.  Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming.

Authors:  David A Balota; Chi-Shing Tse; Keith A Hutchison; Daniel H Spieler; Janet M Duchek; John C Morris
Journal:  Psychol Aging       Date:  2010-03

Review 5.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

6.  Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.

Authors:  Ranjan Duara; David A Loewenstein; Maria T Greig; Elizabeth Potter; Warren Barker; Ashok Raj; John Schinka; Amy Borenstein; Michael Schoenberg; Yougui Wu; Jessica Banko; Huntington Potter
Journal:  Am J Geriatr Psychiatry       Date:  2011-11       Impact factor: 4.105

7.  Sleep onset/maintenance difficulties and cognitive function in nondemented older adults: the role of cognitive reserve.

Authors:  Molly E Zimmerman; Marcelo E Bigal; Mindy J Katz; Adam M Brickman; Richard B Lipton
Journal:  J Int Neuropsychol Soc       Date:  2012-02-09       Impact factor: 2.892

8.  Interest of the new criteria for drug trials in AD.

Authors:  B Dubois
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

9.  Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study.

Authors:  Jared P Reis; Lenore J Launer; James G Terry; Catherine M Loria; Adina Zeki Al Hazzouri; Stephen Sidney; Kristine Yaffe; David R Jacobs; Christopher T Whitlow; Na Zhu; J Jeffrey Carr
Journal:  Atherosclerosis       Date:  2013-09-10       Impact factor: 5.162

10.  Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Authors:  Montse Alegret; Mercè Boada-Rovira; Georgina Vinyes-Junqué; Sergi Valero; Ana Espinosa; Isabel Hernández; Gemma Modinos; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga
Journal:  J Clin Exp Neuropsychol       Date:  2009-01-14       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.